|World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders …|
B Bandelow, J Zohar, E Hollander, S Kasper, HJ Möller, ...
The World Journal of Biological Psychiatry 9 (4), 248-312, 2008
|Epidemiological findings of seasonal changes in mood and behavior: a telephone survey of Montgomery County, Maryland.|
S Kasper, TA Wehr, JJ Bartko, PA Gaist, NE Rosenthal
Archives of general psychiatry, 1989
|The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: acute and long-term treatment of mixed states …|
H Grunze, E Vieta, GM Goodwin, C Bowden, RW Licht, JM Azorin, ...
The World Journal of Biological Psychiatry 19 (1), 2-58, 2018
|Prevalence of seasonal affective disorder at four latitudes|
LN Rosen, SD Targum, M Terman, MJ Bryant, H Hoffman, SF Kasper, ...
Psychiatry research 31 (2), 131-144, 1990
|The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders|
I Pacchiarotti, DJ Bond, RJ Baldessarini, WA Nolen, H Grunze, RW Licht, ...
American Journal of Psychiatry 170 (11), 1249-1262, 2013
|CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants: a first step towards subpopulation‐specific dosages|
J Kirchheiner, K Brøsen, ML Dahl, LF Gram, S Kasper, I Roots, F Sjöqvist, ...
Acta Psychiatrica Scandinavica 104 (3), 173-192, 2001
|Social functioning in depression: a review.|
R Hirschfeld, SA Montgomery, MB Keller, S Kasper, AF Schatzberg, ...
The Journal of clinical psychiatry, 2000
|A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.|
GM Goodwin, CL Bowden, JR Calabrese, H Grunze, S Kasper, R White, ...
The Journal of clinical psychiatry 65 (3), 432, 2004
|Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.|
D Souery, P Oswald, I Massat, U Bailer, J Bollen, K Demyttenaere, ...
Journal of Clinical Psychiatry 68 (7), 1062-1070, 2007
|World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of …|
M Bauer, PC Whybrow, J Angst, M Versiani, HJ Moeller, ...
The World Journal of Biological Psychiatry 3 (1), 5-43, 2002
|Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia|
S Kasper, MN Lerman, RD McQuade, A Saha, WH Carson, M Ali, ...
International Journal of Neuropsychopharmacology 6 (4), 325-337, 2003
|Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder|
J Pierre Olié, S Kasper
International Journal of Neuropsychopharmacology 10 (5), 661-673, 2007
|Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference|
C Johansson, M Willeit, C Smedh, J Ekholm, T Paunio, T Kieseppä, ...
Neuropsychopharmacology 28 (4), 734-739, 2003
|Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder|
A Hahn, P Stein, C Windischberger, A Weissenbacher, C Spindelegger, ...
Neuroimage 56 (3), 881-889, 2011
|The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of …|
H Grunze, E Vieta, GM Goodwin, C Bowden, RW Licht, HJ Möller, ...
The World Journal of Biological Psychiatry 14 (3), 154-219, 2013
|The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania|
H Grunze, E Vieta, GM Goodwin, C Bowden, RW Licht, HJ Moeller, ...
The World Journal of Biological Psychiatry 10 (2), 85-116, 2009
|Reduced serotonin-1A receptor binding in social anxiety disorder|
RR Lanzenberger, M Mitterhauser, C Spindelegger, W Wadsak, N Klein, ...
Biological psychiatry 61 (9), 1081-1089, 2007
|Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a …|
S Kasper, G Hajak, K Wulff, WJG Hoogendijk, A Luis Montejo, E Smeraldi, ...
Journal of clinical psychiatry 71 (2), 109, 2010
|Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care|
B Bandelow, L Sher, R Bunevicius, E Hollander, S Kasper, J Zohar, ...
International journal of psychiatry in clinical practice 16 (2), 77-84, 2012
|Application of transcranial magnetic stimulation in treatment of drug‐resistant major depression—a report of two cases|
G Höflich, S Kasper, A Hufnagel, S Ruhrmann, HJ Möller
Human Psychopharmacology: Clinical and Experimental 8 (5), 361-365, 1993